Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The purpose of this article is to articulate key themes and trends of the FY25 warning letters for drug and biologic products
Highlights will include live cases, featured clinical research, new SCAI clinical documents, case-based learning, and keynote speakers
Administration announces deal to lower GLP-1 prices November 7, 2025 Summary: Yesterdays announcement of lower prices for obesity GLP-1 medications is good news, although impact on prices paid by employers sponsored health plans is not known
)
GLP-1 Persistence is Crucial for Outcomes and ROI A: Medication persistence refers to the patient's ability to stay on the treatment over the prescribed length of time, and is a crucial factor in achieving intended health outcomes
US$ 25.36
US$ 25.86
US$ 26.40
US$ 20.64
